• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

CAY-10603

CAS No. 1045792-66-2

CAY-10603 ( CAY10603 )

产品货号. M10225 CAS No. 1045792-66-2

一种高效、选择性的 HDAC6 抑制剂,IC50 为 2 pM。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥497 有现货
5MG ¥843 有现货
10MG ¥1397 有现货
25MG ¥2688 有现货
50MG ¥3980 有现货
100MG ¥5373 有现货
500MG 获取报价 有现货
1G 获取报价 有现货
1 mL x 10 mM in DMSO ¥845 有现货

生物学信息

  • 产品名称
    CAY-10603
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    一种高效、选择性的 HDAC6 抑制剂,IC50 为 2 pM。
  • 产品描述
    A highly potent and selective HDAC6 inhibitor with IC50 of 2 pM; 200-fold less potent for HDAC3 (IC50=0.42 nM) and no inhibition on HDAC1/2/8/10 (IC50> 100 nM); downregulates the levels of EGFR protein and synergizes with gefitinib to induce apoptosis of the lung adenocarcinoma cell lines.(In Vitro):CAY10603 (Compound 7) shows potent inhibitory activities against pancreatic cancer cell lines, with IC50s of 1, 0.3, 0.1, 0.1, 0.6, <1, 0.5 μM for BxPC-3, HupT3, Mia Paca-2, Panc 04.03, SU.86.86, HMEC, HPDE6c7, respectively. CAY10603 (100 nM, 200-300 nM) is active against both the Mia Paca-2 and Panc04.03 cell lines. CAY10603 inhibits HDAC6 deacetylase activity, and supresses the proliferation of lung adenocarcinoma cells. CAY10603 also induces apoptosis of lung adenocarcinoma cells. Furthermore, CAY10603 synergizes with gefitinib to induce apoptosis in lung adenocarcinoma cell lines, partly through the destabilization of EGFR and inactivation of the EGFR pathway.
  • 体外实验
    CAY10603 (Compound 7) shows potent inhibitory activities against pancreatic cancer cell lines, with IC50s of 1, 0.3, 0.1, 0.1, 0.6, <1, 0.5 μM for BxPC-3, HupT3, Mia Paca-2, Panc 04.03, SU.86.86, HMEC, HPDE6c7, respectively. CAY10603 (100 nM, 200-300 nM) is active against both the Mia Paca-2 and Panc04.03 cell lines. CAY10603 inhibits HDAC6 deacetylase activity, and supresses the proliferation of lung adenocarcinoma cells. CAY10603 also induces apoptosis of lung adenocarcinoma cells. Furthermore, CAY10603 synergizes with gefitinib to induce apoptosis in lung adenocarcinoma cell lines, partly through the destabilization of EGFR and inactivation of the EGFR pathway.
  • 体内实验
    ——
  • 同义词
    CAY10603
  • 通路
    Cell Cycle/DNA Damage
  • 靶点
    HDAC
  • 受体
    HDAC1|HDAC6
  • 研究领域
    Cancer
  • 适应症
    ——

化学信息

  • CAS Number
    1045792-66-2
  • 分子量
    446.4968
  • 分子式
    C22H30N4O6
  • 纯度
    >98% (HPLC)
  • 溶解度
    10 mM in DMSO
  • SMILES
    O=C(OC(C)(C)C)NC1=CC=C(C2=CC(C(NCCCCCCC(NO)=O)=O)=NO2)C=C1
  • 化学全称
    Carbamic acid, N-[4-[3-[[[7-(hydroxyamino)-7-oxoheptyl]amino]carbonyl]-5-isoxazolyl]phenyl]-, 1,1-dimethylethyl ester

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Kozikowski AP, et al. J Med Chem. 2008 Aug 14;51(15):4370-3. 2. Wang Z, et al. Oncol Rep. 2016 Jul;36(1):589-97.
产品手册
关联产品
  • HDAC-IN-40

    HDAC-IN-40 是一种有效的基于烷氧基酰胺的 HDAC 抑制剂,对 HDAC2 和 HDAC6 的 Ki 值分别为 60 nM 和 30 nM。HDAC-IN-40 具有抗肿瘤作用。

  • BRD 8430

    BRD 8430 是一种有效的选择性 I 类 HDAC 抑制剂 (HDAC1>2 >3),对 HDAC1/2/3 的 IC50 分别为 69 nM/560/1300 nM。

  • Remodelin

    乙酰转移酶蛋白 NAT10 的有效抑制剂,可乙酰化组蛋白和微管。